L26/P-871 Needle-free administration of gonadotropins in IVF cycles: a pilot study
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.1195 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von N.D. Dharaiya und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Is needle-free administration of gonadotropins feasible and acceptable during controlled ovarian stimulation in IVF cycles? Summary answer Needle-free gonadotropin delivery was feasible, with satisfactory ovarian response and high treatment continuation among patients completing stimulation. What is known already Daily subcutaneous injections during IVF treatment are associated with discomfort, anxiety, and reduced treatment compliance. Needle-free injection systems have been introduced in other medical specialties and explored in limited IVF settings, suggesting improved patient acceptability. However, clinical feasibility data in routine IVF practice remain limited. Study design, size, duration This prospective pilot feasibility study included 10 patients undergoing IVF treatment, conducted over of 2 months. Participants/materials, setting, methods Patients undergoing controlled ovarian stimulation received gonadotropins via a needle-free injection system. 7 patients completed the stimulation protocol and were included in the final analysis, two patients withdrew during treatment. Ovarian response, cycle progression, and treatment continuation were assessed descriptively to evaluate feasibility and tolerability. Main results and the role of chance Out of the 10 patients initiated, 7 successfully completed ovarian stimulation using the needle-free system. Adequate ovarian response was observed, and in total 90 dominant follicles (18mm ) were seen, out of which 81 COC were retrieved, 68 M2 oocytes seen, no cycle cancellations were attributed to the injection method. Treatment was generally well tolerated, and no major safety concerns related to the device were noted. Given the pilot nature and small sample size, no statistical comparisons were performed. Limitations, reasons for caution Limited small sample size, lack of a control group, and descriptive analysis, precluding conclusions regarding efficacy or comparison with conventional needle-based administration. Wider implications of the findings Needle-free gonadotropin administration appears to be a feasible alternative during IVF stimulation and may enhance patient comfort and acceptability. Larger, controlled studies are required to assess clinical outcomes, patient-reported experience, and cost-effectiveness before routine clinical implementation. Trial registration number No
Zitieren
APA
Dharaiya, N., Patel, U., Das, K., Brahmbhatt, N., & Patel, H. (2026). L26/P-871 Needle-free administration of gonadotropins in IVF cycles: a pilot study. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.1195
Vancouver
Dharaiya N, Patel U, Das K, Brahmbhatt N, Patel H. L26/P-871 Needle-free administration of gonadotropins in IVF cycles: a pilot study. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.1195
BibTeX
@article{Dharaiya2026,
author = {Dharaiya, N.D. and Patel, U. and Das, K. and Brahmbhatt, N. and Patel, H.},
title = {L26/P-871 Needle-free administration of gonadotropins in IVF cycles: a pilot study},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.1195}
}
EUVIMED